[{"arm_notes": "", "treatment_id": null, "treatment_name": "Administer intramuscularly a dose of 0.25 mL or 0.5 mL twice at an interval of 28 days. A dose of 0.25 mL or 0.5 mL is injected intramuscularly at 13 weeks after the second dose.Geometric mean titer of neutralizing antibodies against SARS-CoV-2 (D614) pseudovirus 28 days after the second and third doses of KD-414", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "0.25 mL", "treatment_id": 703, "treatment_name": "Kd-414", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "0.5 mL", "treatment_id": 703, "treatment_name": "Kd-414", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}]